Edarbyclor and Headache - a phase IV clinical study of FDA data

Summary:

Headache is reported as a side effect among people who take Edarbyclor (azilsartan kamedoxomil; chlorthalidone), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Amlodipine, and have Cushing's syndrome.

The phase IV clinical study analyzes which people have Headache when taking Edarbyclor. It is created by eHealthMe based on reports of 1,370 people who have side effects when taking Edarbyclor from the FDA, and is updated regularly.

What is Edarbyclor?

Edarbyclor has active ingredients of azilsartan kamedoxomil; chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 1,412 Edarbyclor users. Check the latest studies of Edarbyclor.

What is Headache?

Headache (pain in head) is found to be associated with 3,758 drugs and 5,776 conditions by eHealthMe. Check the latest studies of Headache.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

1,370 people reported to have side effects when taking Edarbyclor.
Among them, 60 people (4.38%) have Headache.

Among these 60 people:

How long have people been on Edarbyclor when they have Headache? *

What is the gender of people who have Headache when taking Edarbyclor? *

female: 65.38 %
male: 34.62 %

What is the age of people who have Headache when taking Edarbyclor? *

What are other drugs people take besides Edarbyclor? *

What are other side effects people have besides Headache? *

Fatigue (feeling of tiredness): 22 people, 36.67%
Pain In Extremity: 17 people, 28.33%
Dizziness: 15 people, 25.00%
Nausea (feeling of having an urge to vomit): 11 people, 18.33%
Muscle Spasms (muscle contraction): 9 people, 15.00%
Chest Pain: 9 people, 15.00%
Weakness: 9 people, 15.00%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 13.33%
Pain: 8 people, 13.33%
Nausea And Vomiting: 8 people, 13.33%

What are the existing conditions these people have? *

Thyroid Cancer: 4 people, 6.67%
Cushing's Syndrome (obesity, a rounded face, increased fat): 4 people, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 5.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 3.33%
Mineral Metabolism Disorder (disease of mineral utilization by body): 2 people, 3.33%
Osteomalacia (softening of the bones due to a lack of vitamin d): 2 people, 3.33%
Pain: 2 people, 3.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 3.33%
Colon Cancer: 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Edarbyclor and have Headache?

- Check whether Headache is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Edarbyclor:

Edarbyclor (1,412 reports)

Headache treatments and more:

Headache (756,645 reports)

How severe was Headache and when was it recovered:

Headache in Edarbyclor

Expand to all the drugs that have ingredients of azilsartan kamedoxomil; chlorthalidone:

Headache and drugs with ingredients of azilsartan kamedoxomil; chlorthalidone (35 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Edarbyclor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Headache:

Headache (3,758 drugs)

Browse all the conditions that are associated with Headache:

Headache (5,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azilsartan kamedoxomil; chlorthalidone (the active ingredients of Edarbyclor) and Edarbyclor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.